See smaller, see more, see sooner
in early detection of metastases.

The nanoparticle MRI contrast agent Ferrotran®, newly developed by SPL Medical, offers patients with lymph node metastases from prostate cancer a significantly better prognosis. The sooner affected lymph nodes are discovered, the better the chances of recovery with targeted, less invasive treatment. Ferrotran® uses iron oxide nanoparticles to make metastases as small as 2 mm visible, thus making life-saving therapies possible at a significantly earlier point in time.

UNIQUE
EFFECTIVE:

UNIQUE
EFFECTIVE:

FERROTRAN®
REACHES THE LYMPH NODES IN THE BLOOD.
With the help of white blood cells, the macrophages, the iron oxide nanoparticles are transported throughout the body.
METASTASES IN THE LYMPH NODES DO NOT ABSORB THE PARTICLES.
Iron oxide, which is visible on nanoparticle MRI, does not accumulate in a lymph node that is affected by cancer cells.
HEALTHY LYMPH NODES COMPLETELY ABSORB FERROTRAN® .
Non-carcinogenic, metastasis-free lymph nodes accumulate with the iron oxide and are thus visibly colored black for nanoparticle MRI.
HEALTHY LYMPH NODES APPEAR BLACK.
In the high-resolution MRI image, the healthy lymph nodes can be clearly identified by their dark coloring.
METASTATIC LYMPH NODES APPEAR WHITE ON NANOPARTICLE MRI.
Cancer cells in the lymph nodes now clearly stand out brightly in front of those that are dark colored by nanoparticles and can be precisely localized for more targeted therapy.
EVEN THE SMALLEST METASTASES ARE IMMEDIATELY RECOGNIZABLE.
Ferrotran® is the only contrast agent that can make metastases from 2 mm visible.
Animation überspringen

The advantages
of Ferrotran®

High-contrast
imaging in
the MRI.

Black for healthy tissue, white for cancerous tissue.

Also shows smaller metastases.


Crucial for successful therapy.

Well tolerated active ingredient.


Non-radioactive ultra-small iron oxide particles (USPIOs).

Easy to administer.


Intravenously 24-36 hours before the MRI scan.

Available anywhere, anytime.

No decaying radioisotopes, therefore storable.

Superior to conventional methods.

Clinical studies prove the more precise diagnosis.

This is how Ferrotran®
is used in patients:

You want to know more
about Ferrotran®?

Ferrotran® for doctors

Learn more

Ferrotran® for investors

Learn more

SPL MEDICAL NEWSLETTER

Abonnieren Sie unseren Newsletter und bleiben Sie in Sachen SPL-Medical und Ferrotran® auf dem Laufendem.

Anmelden